靶点针对疾病信息16(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Lymphocyte activation antigen CD30 (TNFRSF8)
INDICATI
Approved Hodgkin lymphoma [ICD-11: 2B30]
INDICATI
Phase 2 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 2 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 2 Mature T-cell lymphoma [ICD-11: 2A90]
INDICATI
Phase 2 Mycosis fungoides [ICD-11: 2B01]
INDICATI
Phase 1/2 B-cell lymphoma [ICD-11: 2A86]
INDICATI
Phase 1/2 Immune system disease [ICD-11: 4A01-4B41]
INDICATI
Phase 1/2 Immunoproliferative disorder [ICD-11: 2B32]
INDICATI
Phase 1/2 Leukaemia [ICD-11: 2A60-2B33]
INDICATI
Phase 1/2 Lymphatic vessel/lymph nodes disorder [ICD-11: BD9Z]
INDICATI
Phase 1/2 Multiple myeloma [ICD-11: 2A83]
INDICATI
Investigative Diabetes mellitus [ICD-11: 5A10]